Victorian healthcare leaders ensure that our work is impactful, ethical and sustainable.

Board of Directors

The Board of Directors comprises leaders of the 10 member organisations of the Melbourne Genomics Health Alliance, an Independent Director, and an Independent Chair.

The Board provides oversight of the Alliance’s program of work, establishing appropriate strategies, objectives and policies.

The Board is chaired by Catherine Walter AM, a lawyer and company director. A representative from the Victorian Department of Jobs, Precincts and Regions is appointed as an Observer.

Meet our Board members

Committees of the Board

Finance, Audit and Risk Committee

This committee assists the Board in fulfilling its statutory, fiduciary and regulatory responsibilities in respect of oversight, risk management and corporate governance. It also assists in fostering a strategic approach to financial management and a risk aware culture.

It is chaired by Adam Horsburgh, CEO of Austin Health.

Business Development and Commercialisation Committee

This committee assists the Board to maximise the value of the program and its assets, monitor the realisation of commercial outcomes, and deliver long-term economic benefits. It also advises on business development opportunities and risks.

It is chaired by Dr Dan Grant, former Managing Director and CEO of MTPConnect.

Advisory bodies

Community Advisory Group

Champions of consumer rights in healthcare, the members of this group advise on community engagement for each of our projects: when it is needed, how to approach it, and whose voices must be heard.

Meet the group and its Chair, Jane Bell.

Subscribe

We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2022 Melbourne Genomics Health Alliance